Skip to main content
. 2020 Aug 12;12(8):e9687. doi: 10.7759/cureus.9687

Table 1. Clinical and demographic characteristics of the study population.

TNF: tumor necrosis factor

  Ulcerative colitis, n (%); n=18 Crohn’s disease, n (%); n=53 Total, n (%); n=71
Sociodemographic characteristics  
Age group (years) <20 3 (16.7%) 7 (13.2%) 10 (14.1%)
20–40 10 (55.6%) 43 (91.1%) 53 (74.6%)
>40 5 (27.8%) 3 (5.7%) 8 (11.3%)
Gender Female 10 (55.6%) 22 (41.5%) 32 (45.1%)
Male 8 (44.4%) 31 (58.5%) 39 (54.9%)
Marital status Married 10 (55.6%) 20 (37.7%) 30 (42.3%)
Unmarried 8 (44.4%) 33 (62.3%) 41 (57.7%)
Smoking 2 (11.1%) 12 (22.6%) 14 (19.7%)
Educational level Elementary school 2 (11.1%) 2 (3.8%) 4 (5.6%)
High school and diploma 6 (33.3%) 23 (43.4%) 29 (40.9%)
University degree 10 (55.6%) 28 (52.8%) 38 (53.5%)
Household income per month (Saudi riyal) <5,000 6 (33.3%) 27 (50.9%) 33 (46.5%)
5,000–10,000 6 (33.3%) 21 (39.6%) 27 (38%)
>10,000 6 (33.3%) 5 (9.4%) 11 (15.5%)
Residential area Urban 17 (94.4%) 52 (98.1%) 69 (97.2%)
Rural 1 (5.6%) 1 (1.9%) 2 (2.8%)
Clinical features  
Disease duration (years) ≤6 12 (66.7%) 34 (64.2%) 46 (64.8%)
>6 6 (33.3%) 19 (35.8%) 25 (35.2%)
Symptoms Abdominal pain 15 (83.3%) 49 (92.5%) 64 (90.1%)
Watery diarrhea 14 (77.8%) 32 (60.4%) 46 (64.8%)
Nausea/vomiting 9 (50%) 34 (64.2%) 43 (60.6%)
Rectal bleeding 15 (83.3%) 23 (44.2%) 38 (54.3%)
Medications Corticosteroids 4 (22.2%) 10 (18.9%) 14 (19.7%)
Mesalamine 6 (33.3%) 11 (20.8%) 17 (23.9%)
Azathioprine 2 (11.1%) 18 (34%) 20 (28.2%)
Anti-TNF therapy 4 (22.2%) 25 (47.2%) 29 (40.8%)